Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Haemonetics Corporation (HAE) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-03-31

Income Statement Financials
Revenue	$1.36B
Net Income	$167.68M
Cost of Goods Sold	$611.87M
Gross Profit	$748.96M
Operating Expenses	$1.14B
Operating Income	$221.82M
Non-Operating Income/Expense	$-9.75M
Pre-Tax Income	$212.07M
Normalized Pre-Tax Income	$212.07M
Income after Taxes	$167.68M
Income from Continuous Operations	$167.68M
Consolidated Net Income/Loss	$167.68M
Normalized Income after Taxes	$167.68M
EBIT	$221.82M
EBITDA	$352.36M
Weighted-Average Shares Outstanding (Basic)	50.33M
Weighted-Average Shares Outstanding (Diluted)	50.73M
Earnings per Share (EPS) (Basic)	$3.33
Earnings per Share (EPS) (Diluted)	$3.31
Balance Sheet Financials
Current Assets	$934.98M
Property, Plant, and Equipment	$284.05M
Long-Term Assets	$1.52B
Total Assets	$2.45B
Current Liabilities	$578.11M
Long-Term Debt	$921.23M
Long-Term Liabilities	$1.05B
Total Liabilities	$1.63B
Common Equity	$820.84M
Tangible Shareholders Equity	$-239.18M
Shareholders Equity	$820.84M
Common Shares Outstanding	48.22M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$181.72M
Cash Flow from Investing Activities	$-161.90M
Cash Flow from Financial Activities	$108.82M
Beginning Cash	$178.80M
End Cash	$306.76M
Increase/Decrease in Cash	$127.96M
Stock-Based Compensation	$29.64M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.62
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.53
Debt to Equity Ratio	1.49
Gross Margin	55.04%
Operating Margin	16.30%
EBIT Margin	16.30%
EBITDA Margin	25.89%
Pre-Tax Profit Margin	15.58%
Profit Margin	12.32%
Free Cash Flow	$165.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.56
Inventory Turnover	1.68
Receiveable Turnover	6.71
Days Sales in Receivables	54.36
Return on Equity	20.43%
Return on Tangible Equity	-70.11%
Return on Assets	6.84%
Return on Investments	9.63%
Book Value Per Share	$17.02
Free Cash Flow per Share	$3.27
Operating Cash Flow per Share	$3.58

Data from Zacks Investment Research, Inc.